💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Alexion Pharmaceuticals, Inc. (ALXN)
« Back to company indexALXN Chatter Timeline
Stock Ticker for ALXN
Most Active Tweeters for ALXN
| User | Tweets |
|---|---|
| @poodirg | 1 |
Recent Tweets for ALXN
 |
@poodirg $ALXN the CEO gets the pay of 18 million/year. A huge number! Higher than the payment received many other CEOs in the industry. December 1st 2021, 1:12am |
|
@eoobook $ALXN The annual salary of the CEO is 18 million/year; too high to accept! as it is 43% higher than the level estim… https://t.co/VIlEtUqPIz November 18th 2021, 7:11am |
 |
@PredatorDiaries My [email protected]? column this week on the effect of $AZN’s ‘Spider-Man’ acquisition of $ALXN - great acquisitions b… https://t.co/JIj1fLaPja November 15th 2021, 9:11pm |
 |
@aersgrg $ALXN The annual salary of the CEO is 18 million/year; too high to accept! as it is 43% higher than the level estim… https://t.co/GhxMuYn1hr November 15th 2021, 3:11am |
|
@dicotpo The CEO remuneration of $ALXN is 18 million/year. Few companies in the industry pay such a level. Does the company… https://t.co/E7bZaD7n8D November 1st 2021, 4:11pm |
 |
@adamfeuerstein @WillPeterman3 I remember the same. That was significant shift for a respected CFO, and well-received housecleaning at $ALXN. October 28th 2021, 5:10pm |
 |
@WillPeterman3 @adamfeuerstein I recall $BIIB losing 3% and $ALXN gaining over 9% on the day Paul Clancy’s departure was announced… https://t.co/Io5zPL1kyy October 28th 2021, 5:10pm |
 |
@CSIMarket $ALXN #StockMarket On October 28, #AlexionPharmaceuticals likely to report the second quarter of 2021 EarningsRepo… https://t.co/smgjAuLkrE October 28th 2021, 7:10am |
 |
@avidresearch @nolastevedore thought complement factor C5a already explored by $ALXN and study failed. https://t.co/15pONwNkn4 October 27th 2021, 6:10pm |
 |
@Dani82909403 $AUPH Hope this becomes my second takeover this year after I held $ALXN!!! ? ?? https://t.co/cOj3BWVGmt Use Coupo… https://t.co/ZlMdqOdKgh October 23rd 2021, 5:10pm |
|
@pettteh1 $ALXN CEO’s annual remuneration is 18 million, higher than the level predicted by the firm’s fundamentals by 43%. An overpay problem! October 16th 2021, 1:10am |
 |
@YuZhu4 RT @Sports_bios: $VRTX could be the next $ALXN in both the concerns once growth has attenuated and potential prospects for a buyer.. the b… October 7th 2021, 3:10am |
 |
@Sports_bios $VRTX could be the next $ALXN in both the concerns once growth has attenuated and potential prospects for a buyer..… https://t.co/Zu5lagkQjE October 6th 2021, 5:10pm |
|
@aha_kkk My calculation shows that the annual payment of $ALXN's CEO is 18 million, 43% higher than the theoretical level it… https://t.co/trAfbdjFe3 October 2nd 2021, 7:10am |
 |
@beercules47 @Sanctuary_Bio Idk what people expected the durability of HSCT-TMA to be either, with $ALXN and $APLS maybe two yea… https://t.co/KKPFEvjuIk October 1st 2021, 1:10pm |
 |
@BioPharmaWolf wasn't it supposed to be the next $ALXN? While narsoplimab had good data in HSCT-TMA, this setback won't help. Ult… https://t.co/5cxnbpLE0Q October 1st 2021, 1:10pm |
|
@aha_kkk My calculation shows that the annual payment of $ALXN’s CEO is 18 million, 43% higher than the theoretical level it… https://t.co/ZDPJbrKR54 October 1st 2021, 2:10am |
 |
@SnackBioTech @retailbiotech @BiotechElmo I'm very bullish $ALXN. It has been stable no matter what. September 29th 2021, 9:09pm |
 |
@newsfilterio AstraZeneca to invest $360 million in new Irish drug manufacturing site $ALXN https://t.co/ymOVvhGVrn September 21st 2021, 6:09am |
 |
@JuliaEv04824165 $ALXN Real price will come out soon; Follow price targets,,, https://t.co/kpn1ZkXtR4 September 17th 2021, 7:09am |
|
@jpiipj The CEO annual payment of $ALXN is 18 million, 1.4 times larger than it should be (as it fundamentals predict). The… https://t.co/OjVHlm3Yjp September 15th 2021, 7:09am |
 |
@getbillasap @semodough @laxr2020 $ALXN also involved shares and not straight cash. Apples and oranges $TRIL September 14th 2021, 8:09pm |
|
@laxr2020 @semodough Look for how $ALXN acted for months, more than 15% spread at one point September 14th 2021, 4:09pm |
 |
@TraderOfStocks1 $ALXN Must read: https://t.co/YI7pjEpBnA September 14th 2021, 4:09am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?